Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Facharzt/-ärztin, Klinik für Urologie
Aktuelle Veranstaltungen
-
SoSe 2025
- Experimentell uro-onkologisches Doktorandenseminar
- Ausbildung Urologie für den 3. klinischen Studienabschnitt
- Röntgendiagnostik (i. Rahmen des Praktikums) (PV)
- Intensivkurs Sonographie
- Urindiagnostik (Urinsediment, Zytologie, Erythrozytenmorphologie)
- Urologie, Uroonkologie, rekonstruktive Urologie, Andrologie, Kinderurologie (WA)
- Praktikum der Urologie (2. Sem. d. zweiten Abschnitts) (PV)
Vergangene Veranstaltungen (max. 10)
-
WiSe 2024
- Intensivkurs Sonographie
- Röntgendiagnostik (i. Rahmen des Praktikums) (PV)
- Ausbildung Urologie für den 3. klinischen Studienabschnitt
- Praktikum der Urologie (2. Sem. d. zweiten Abschnitts) (PV)
- Experimentell uro-onkologisches Doktorandenseminar
- Urologie, Uroonkologie, rekonstruktive Urologie, Andrologie, Kinderurologie (WA)
- Urindiagnostik (Urinsediment, Zytologie, Erythrozytenmorphologie)
-
SoSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Impact of Extended Versus Limited Lymph Node Dissection on Surgical Outcome, Recurrence Patterns and Survival After Radical CystectomyIn: Clinical Genitourinary Cancer , Jg. 23 2025, Nr. 3, 102337
-
Temporal patterns of major postoperative events after radical cystectomy : Analysis of 90-day morbidityIn: World Journal of Urology , Jg. 43 2025, Nr. 1, 111
-
Bricker versus Wallace ureteroileal anastomosis : A multi-institutional propensity score-matched analysisIn: International Journal of Urology , Jg. 31 2024, Nr. 7, S. 813 – 818
-
Near-infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device : A single center experienceIn: Journal of Surgical Oncology , Jg. 129 2024, Nr. 7, S. 1325 – 1331DOI (Open Access)
-
Outcomes of surgical therapy for local recurrence and oligometastatic urothelial carcinoma of the bladder : 20 years of experience in a tertiary centerIn: Urologia Internationalis 2024 , in press
-
Risk factors for ureteroenteric stricture after radical cystectomy and urinary diversion : A systematic reviewIn: Arab Journal of Urology , Jg. 22 2024, Nr. 1, S. 61 – 69DOI (Open Access)
-
The current role of pentafecta in the reporting of radical cystectomy outcomes : a scoping reviewIn: Translational Andrology and Urology , Jg. 13 2024, Nr. 6, S. 1037 – 1048DOI (Open Access)
-
The impact of double-J ureteral stenting before radical cystectomy on the development of upper tract urothelial carcinomaIn: Minerva Urology and Nephrology , Jg. 76 2024, Nr. 4, S. 442 – 451
-
18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in MenIn: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 4, S. 598 – 604DOI (Open Access)
-
Der Stellenwert der Penumbra in der gezielten ProstatabiopsieIn: Die Urologie , Jg. 62 2023, Nr. 1, S. 75 – 76
-
Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy : A Prospective Randomized TrialIn: European Urology Oncology , Jg. 6 2023, Nr. 1, S. 49 – 55
-
Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? : A Dosimetric and Radiobiological Comparison StudyIn: Current Oncology , Jg. 30 2023, Nr. 1, S. 758 – 768DOI, Online Volltext (Open Access)
-
Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric strictureIn: Langenbeck's Archives of Surgery , Jg. 407 2022, Nr. 3, S. 1233 – 1240DOI (Open Access)
-
Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacerIn: Radiation Oncology , Jg. 17 2022, Nr. 1, 64DOI, Online Volltext (Open Access)
-
Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial CarcinomaIn: Biomedicines , Jg. 10 2022, Nr. 3, 698DOI, Online Volltext (Open Access)
-
High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial CarcinomaIn: Biomedicines , Jg. 10 2022, Nr. 10, 2560DOI (Open Access)
-
Radiation Protection and Occupational Exposure on ⁶⁸Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted ProstatectomyIn: Journal of Nuclear Medicine (JNM) , Jg. 63 2022, Nr. 9, S. 1349 – 1356DOI (Open Access)
-
Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer : A Retrospective Analysis of a Single-Centre CohortIn: Urologia Internationalis , Jg. 106 2022, S. 638 – 643DOI (Open Access)
-
Three-dimensional Magnetic Resonance Imaging-based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy : A Feasibility StudyIn: European Urology Oncology , Jg. 5 2022, Nr. 3, S. 357 – 361DOI (Open Access)
-
Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography–fusion BiopsyIn: European Urology Focus , Jg. 7 2021, Nr. 6, S. 1300 – 1307DOI (Open Access)
-
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranosticsIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 49 2021, S. 385 – 389DOI (Open Access)
-
High serum pd-l1 levels are associated with poor survival in urothelial cancer patients treated with chemotherapy and immune checkpoint inhibitor therapyIn: Cancers , Jg. 13 2021, Nr. 11, 2548DOI, Online Volltext (Open Access)
-
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer PatientsIn: Diagnostics , Jg. 11 2021, Nr. 1, 48DOI, Online Volltext (Open Access)
-
Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfallsIn: Translational Andrology and Urology , Jg. 10 2021, Nr. 10, S. 3972 – 3985DOI (Open Access)
-
The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapyIn: Urologic Oncology: Seminars and Original Investigations , Jg. 39 2021, Nr. 5, S. 296.e11 – 296.e19DOI (Open Access)
-
Transrectal Ultrasound Guided Hydrodistension : A New Surgical Way in Transgender SurgeryIn: The Journal of Sexual Medicine , Jg. 18 2021, Nr. 6, S. 1134 – 1140
-
External validation of novel magnetic resonance imaging-based models for prostate cancer predictionIn: BJU International (BJUI) , Jg. 125 2020, Nr. 3, S. 407 – 416
-
First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using ⁶⁸Ga-PSMA-11In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 47 2020, Nr. 13, S. 3194 – 3195
-
Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder : a randomized study in comparison with white light cystoscopyIn: World Journal of Urology , Jg. 38 2020, Nr. 6, S. 1509 – 1515
-
Renal duplication with ureter duplex not following Meyer-Weigert-Rule with development of a megaureter of the lower ureteral segment due to distal stenosis – A case reportIn: Urology Case Reports , Jg. 28 2020, 101038DOI (Open Access)
-
STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer PatientsIn: Pathology & Oncology Research , Jg. 26 2020, Nr. 2, S. 1243 – 1249
-
Serum and tissue syndecan-1 levels in renal cell carcinomaIn: Translational Andrology and Urology , Jg. 9 2020, Nr. 3, S. 1167 – 1176DOI (Open Access)
-
Soluble syndecan-1 levels are associated with survival in platinum-treated bladder cancer patientsIn: Diagnostics , Jg. 10 2020, Nr. 11, 864DOI, Online Volltext (Open Access)
-
Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinomaIn: International Journal of Cancer , Jg. 145 2019, Nr. 2, S. 531 – 539
-
Systemtherapie des metastasierten Tumors des oberen HarntraktesIn: Der Urologe , Jg. 58 2019, Nr. 1, S. 30 – 33
-
Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancerIn: Urologic Oncology: Seminars and Original Investigations , Jg. 37 2019, Nr. 11, S. 810.e7 – 810.e15
-
Ergebnisse der LuPSMA-Studie zeigen hohe Ansprechraten mit geringer Toxizität und SchmerzlinderungIn: Der Urologe , Jg. 57 2018, Nr. 12, S. 1494 – 1495
-
Erratum zu : Wie sollen Urologen venöse subkutane Portsysteme implantieren?: Erfahrungen an einem Zentrum bei 347 PatientenIn: Der Urologe , Jg. 57 2018, Nr. 8, S. 968DOI (Open Access)
-
Integrated ⁶⁸Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance ImagingIn: Urologia Internationalis , Jg. 100 2018, Nr. 2, S. 164 – 171
-
The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate CancerIn: Urologia Internationalis , Jg. 101 2018, Nr. 1, S. 65 – 73
-
Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific SurvivalIn: Pathology & Oncology Research , Jg. 23 2017, Nr. 3, S. 643 – 650
-
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell CancerIn: The Journal of Urology , Jg. 195 2016, Nr. 4, S. 1120 – 1125
-
Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancerIn: The Prostate , Jg. 76 2016, Nr. 11, S. 977 – 985
-
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay methodIn: International Urology and Nephrology , Jg. 48 2016, Nr. 3, S. 355 – 361
-
Diagnostik beim nicht-muskelinvasiven Urothelkarzinom der HarnblaseIn: Der Urologe , Jg. 54 2015, Nr. 4, S. 480 – 483
-
Mistletoe plant extract in patients with nonmuscle invasive bladder cancer : Results of a phase Ib/IIa single group dose escalation studyIn: The Journal of Urology , Jg. 194 2015, Nr. 4, S. 939 – 943
-
Renal cell carcinoma and tumour thrombus in the inferior vena cava : clinical outcome of 98 consecutive patients and the prognostic value of preoperative parametersIn: World Journal of Urology , Jg. 33 2015, Nr. 10, S. 1541 – 1552
-
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancerIn: Human Pathology , Jg. 45 2014, Nr. 4, S. 674 – 682
-
Erratum zu : Urothelkarzinom der Harnblase. Organerhaltende TherapiestrategienIn: Der Urologe , Jg. 53 2014, Nr. 12, S. 1832
-
Organ- und Funktionserhalt beim NierenzellkarzinomIn: Der Urologe , Jg. 53 2014, Nr. 9, S. 1329 – 1343
-
Prognostic effect of serum and tissue YKL-40 levels in bladder cancerIn: Urologic Oncology: Seminars and Original Investigations , Jg. 32 2014, Nr. 5, S. 663 – 669
-
Prognostic value of tissue and circulating levels of IMP3 in prostate cancerIn: International Journal of Cancer , Jg. 135 2014, Nr. 7, S. 1596 – 1604DOI (Open Access)
-
Urothelkarzinom der Harnblase : Organerhaltende TherapiestrategienIn: Der Urologe , Jg. 53 2014, Nr. 9, S. 1322 – 1328DOI (Open Access)
-
Erratum zu: Die endoskopische Behandlung der HarnröhrenstrikturIn: Der Urologe: Ausgabe A , Jg. 52 2013, Nr. 4, S. 583 – 583
-
MMP-7-Bestimmung im Urin basierend auf Siliziumchiptechnologie : Eine Möglichkeit zur präoperativen Identifizierung von Lymphknotenmetastasen beim HarnblasenkarzinomIn: Der Urologe , Jg. 52 2013, Nr. 6, S. 853 – 858
-
Urologische Operationen in Analgosedierung und Lokalanästhesie : was ist sinnvoll?In: Der Urologe , Jg. 52 2013, Nr. 9, S. 1302 – 1313
-
Instillationstherapie des nichtmuskelinvasiven HarnblasenkarzinomsIn: Der Urologe , Jg. 51 2012, Nr. 2, S. 257 – 264
-
Tissue MMP-7 expression predicts survival in bladder cancer patients treated with cisplatin-based chemotherapyIn: The Journal of Urology , Jg. 187 2012, Nr. Suppl. 4, S. E575 – E575
-
Wie sollen Urologen venöse subkutane Portsysteme implantieren? : Erfahrungen an einem Zentrum bei 347 PatientenIn: Der Urologe , Jg. 51 2012, Nr. 2, S. 226 – 237
-
Correlation of pathological and cytological-cytometric grading of transitional cell carcinoma of the urinary tractIn: Urologia Internationalis , Jg. 86 2011, Nr. 1, S. 36 – 40
-
Exfoliative Urinzytologie in der Behandlung des HarnblasenkarzinomsIn: Der Urologe , Jg. 50 2011, Nr. 3, S. 292 – 296
-
Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladderIn: Oncology Letters , Jg. 2 2011, Nr. 6, S. 1149 – 1153DOI (Open Access)
-
Photodynamische Diagnostik des HarnblasenkarzinomsIn: Der Urologe , Jg. 50 2011, Nr. 9, S. 1068 – 1071
-
Urothelkarzinom der Harnblase : Kombinierte endoskopische und urinzytologische Beurteilung: Lässt es sich sicher einschätzen?In: Der Urologe , Jg. 50 2011, Nr. 6, S. 702 – 705
-
Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder CancerIn: Pathology & Oncology Research , Jg. 17 2011, Nr. 2, S. 325 – 332
-
Nichtmuskelinvasives Urothelkarzinom : Ist die Anwendung von BCG noch notwendig?In: Die Urologie , Jg. 49 2010, Nr. 10, S. 1274 – 1276
-
Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging/transrectal ultrasonography-fusion biopsy : A prospective, randomized comparison to conventional target biopsy
EAU21 Virtual Congress; 8-12 July 2021; Virtual,In: European Urology , Jg. 79 2021, Nr. Suppl. 1, S. S1272 -
Ga-68-versus F-18-PSMA for Cerenkov Luminescence and autoradiography in a prostate cancer mouse model
EANM‘21, Annual Congress of the European Association of Nuclear Medicine, October 20-23, 2021, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 48 2021, Nr. Suppl. 1, S. S17DOI (Open Access) -
Zytologisch-zytometrische Reklassifizierung der ehemaligen G2-Urothelkarzinome in low grade und high grade Karzinome nach der WHO-Klassifikation von 2004Duisburg, Essen 2009
-
Klinisch-dosimetrische Aspekte der Online-Planadaptation bei der kurativen Strahlentherapie lokal begrenzter urogenitaler Tumore : erste Erfahrungen mit dem Ethos®- System
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S71 – S72DOI (Open Access)